Heron Therapeutics
HRTX
$2.45
Share price
-3.92%
Change (1 day)
2.51%
Change (1 year)
Categories
Heron Therapeutics (HRTX) - Total assets
Total assets on the balance sheet as of December 2023 : $0.22 B
According to Heron Therapeutics's latest financial reports the company's total assets are $0.22 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Heron Therapeutics - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.22 B | -11.33% |
| 2022-12-31 | $0.25 B | -17.91% |
| 2021-12-31 | $0.30 B | -13.53% |
| 2020-12-31 | $0.35 B | -31.05% |
| 2019-12-31 | $0.51 B | 10.95% |
| 2018-12-31 | $0.46 B | 97.25% |
| 2017-12-31 | $0.23 B | 247.21% |
| 2016-12-31 | $67.48 M | -51.05% |
| 2015-12-31 | $0.13 B | 79.76% |
| 2014-12-31 | $76.68 M | 0.98% |
| 2013-12-31 | $75.93 M | 35.67% |
| 2012-12-31 | $55.97 M | 187.85% |
| 2011-12-31 | $19.44 M | 567.98% |
| 2010-12-31 | $2.91 M | -67.48% |
| 2009-12-31 | $8.95 M | -24.14% |
| 2008-12-31 | $11.8 M | -68.06% |
| 2007-12-31 | $36.95 M | 114.19% |
| 2006-12-31 | $17.25 M | 92.34% |
| 2005-12-31 | $8.96 M | -47.28% |
| 2004-12-31 | $17.01 M | 29.33% |
| 2003-12-31 | $13.15 M | -26.02% |
| 2002-12-31 | $17.78 M | -24.36% |
| 2001-12-31 | $23.5 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | $0.18 B | -19.00% | 🇺🇸 USA |
 Pacira Biosciences
PCRX | $1.57 B | 607.57% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.78 B | 253.80% | 🇺🇸 USA |
 Alkermes ALKS | $2.13 B | 860.07% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | $0.39 B | 78.89% | 🇺🇸 USA |